Artigos de revistas sobre o tema "MET/HGF"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "MET/HGF".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Toiyama, Y., K. Tanaka, H. Yasuda, S. Saigusa, H. Fujikawa, Y. Mohri, Y. Inoue, C. Miki, T. Tabata e M. Kusunoki. "Use of co-expression of HGF and c-Met to predict peritoneal dissemination established by autocrine HGF/c-Met signaling in gastric cancer." Journal of Clinical Oncology 29, n.º 4_suppl (1 de fevereiro de 2011): 40. http://dx.doi.org/10.1200/jco.2011.29.4_suppl.40.
Texto completo da fonteZhang, Hongli, Qingqing Feng, Wei-Dong Chen e Yan-Dong Wang. "HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers". International Journal of Molecular Sciences 19, n.º 11 (23 de outubro de 2018): 3295. http://dx.doi.org/10.3390/ijms19113295.
Texto completo da fonteWeimar, Iris S., Daphne de Jong, Egbert J. Muller, Toshikazu Nakamura, Joost M.H.H. van Gorp, Gijsbert C. de Gast e Winald R. Gerritsen. "Hepatocyte Growth Factor/Scatter Factor Promotes Adhesion of Lymphoma Cells to Extracellular Matrix Molecules Via α4β1 and α5β1 Integrins". Blood 89, n.º 3 (1 de fevereiro de 1997): 990–1000. http://dx.doi.org/10.1182/blood.v89.3.990.
Texto completo da fonteGallo, Simona, Valentina Sala, Stefano Gatti e Tiziana Crepaldi. "Cellular and molecular mechanisms of HGF/Met in the cardiovascular system". Clinical Science 129, n.º 12 (11 de novembro de 2015): 1173–93. http://dx.doi.org/10.1042/cs20150502.
Texto completo da fonteDe Silva, Dinuka M., Arpita Roy, Takashi Kato, Fabiola Cecchi, Young H. Lee, Kunio Matsumoto e Donald P. Bottaro. "Targeting the hepatocyte growth factor/Met pathway in cancer". Biochemical Society Transactions 45, n.º 4 (3 de julho de 2017): 855–70. http://dx.doi.org/10.1042/bst20160132.
Texto completo da fonteKauma, Scott, Natalie Hayes e Shannon Weatherford. "The Differential Expression of Hepatocyte Growth Factor and Met in Human Placenta*". Journal of Clinical Endocrinology & Metabolism 82, n.º 3 (1 de março de 1997): 949–54. http://dx.doi.org/10.1210/jcem.82.3.3806.
Texto completo da fonteYamasaki, Koji, Shoichiro Mukai, Takahiro Nagai, Kozue Nakahara, Masato Fujii, Naoki Terada, Akinobu Ohno et al. "Matriptase-Induced Phosphorylation of MET is Significantly Associated with Poor Prognosis in Invasive Bladder Cancer; an Immunohistochemical Analysis". International Journal of Molecular Sciences 19, n.º 12 (22 de novembro de 2018): 3708. http://dx.doi.org/10.3390/ijms19123708.
Texto completo da fonteWoolf, A. S., M. Kolatsi-Joannou, P. Hardman, E. Andermarcher, C. Moorby, L. G. Fine, P. S. Jat, M. D. Noble e E. Gherardi. "Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros." Journal of Cell Biology 128, n.º 1 (1 de janeiro de 1995): 171–84. http://dx.doi.org/10.1083/jcb.128.1.171.
Texto completo da fonteTanaka, Ryota, Mizue Terai, Eric Londin e Takami Sato. "The Role of HGF/MET Signaling in Metastatic Uveal Melanoma". Cancers 13, n.º 21 (30 de outubro de 2021): 5457. http://dx.doi.org/10.3390/cancers13215457.
Texto completo da fonteCzyz, Malgorzata. "HGF/c-MET Signaling in Melanocytes and Melanoma". International Journal of Molecular Sciences 19, n.º 12 (3 de dezembro de 2018): 3844. http://dx.doi.org/10.3390/ijms19123844.
Texto completo da fonteKumar, Vinod, Zachary A. Yochum, Princey Devadassan, Eric Huang, Ethan Miller, Vasavi Ayyala, Laura P. Stabile, Timothy F. Burns e Purva H. Rumde. "Abstract 1091: TWIST1 inhibition overcomes resistance to tyrosine kinase inhibitors in MET driven non-small cell lung cancer". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 1091. http://dx.doi.org/10.1158/1538-7445.am2022-1091.
Texto completo da fonteSato, Hiroki, Ryu Imamura, Hiroaki Suga, Kunio Matsumoto e Katsuya Sakai. "Cyclic Peptide-Based Biologics Regulating HGF-MET". International Journal of Molecular Sciences 21, n.º 21 (27 de outubro de 2020): 7977. http://dx.doi.org/10.3390/ijms21217977.
Texto completo da fonteKentsis, Alex, Takaomi Sanda, Vu Ngo, Scott J. Rodig, Jeffery Kutok, Eleni Tholouli, Richard Byers et al. "Aberrant Expression of Hepatocyte Growth Factor Induces Autocrine MET Activation Providing a Novel Therapeutic Target In Acute Myeloid Leukemia." Blood 116, n.º 21 (19 de novembro de 2010): 1042. http://dx.doi.org/10.1182/blood.v116.21.1042.1042.
Texto completo da fonteMcInnis, Ian, Theresa Hahn, Anasitasia Ioane, Ashleigh Lamson, Deepika Lal, Laurie Ann Ford, Sheila NJ Sait et al. "Diverse Roles of Hepatocyte Growth Factor (HGF) in Normal Karyotype Acute Myeloid Leukemia (AML)." Blood 114, n.º 22 (20 de novembro de 2009): 3107. http://dx.doi.org/10.1182/blood.v114.22.3107.3107.
Texto completo da fonteZhou, Si-Rui, Wen-Ting Yuan, Xiao-Yan Pan, Tong Wang e Xiao-Dong Chen. "Hepatocyte growth factor promotes retinal pigment epithelium cell activity through MET/AKT signaling pathway". International Journal of Ophthalmology 17, n.º 5 (18 de maio de 2024): 806–14. http://dx.doi.org/10.18240/ijo.2024.05.03.
Texto completo da fonteBorset, M., H. Hjorth-Hansen, C. Seidel, A. Sundan e A. Waage. "Hepatocyte growth factor and its receptor c-met in multiple myeloma". Blood 88, n.º 10 (15 de novembro de 1996): 3998–4004. http://dx.doi.org/10.1182/blood.v88.10.3998.bloodjournal88103998.
Texto completo da fonteAnastasi, Sergio, Silvia Giordano, Olga Sthandier, Giovanna Gambarotta, Rossella Maione, Paolo Comoglio e Paolo Amati. "A Natural Hepatocyte Growth Factor/Scatter Factor Autocrine Loop in Myoblast Cells and the Effect of the Constitutive Met Kinase Activation on Myogenic Differentiation". Journal of Cell Biology 137, n.º 5 (2 de junho de 1997): 1057–68. http://dx.doi.org/10.1083/jcb.137.5.1057.
Texto completo da fonteTahira, Yumiko, Katsuya Sakai, Hiroki Sato, Ryu Imamura e Kunio Matsumoto. "Dimer Interface in Natural Variant NK1 Is Dispensable for HGF-Dependent Met Receptor Activation". International Journal of Molecular Sciences 22, n.º 17 (26 de agosto de 2021): 9240. http://dx.doi.org/10.3390/ijms22179240.
Texto completo da fonteChang, Chih-Ching, Jia-Jhen Chiu, Shan-Ling Chen, Hui-Chun Huang, Hui-Fen Chiu, Bo-Huei Lin e Chun-Yuh Yang. "Activation of HGF/c-Met signaling by ultrafine carbon particles and its contribution to alveolar type II cell proliferation". American Journal of Physiology-Lung Cellular and Molecular Physiology 302, n.º 8 (15 de abril de 2012): L755—L763. http://dx.doi.org/10.1152/ajplung.00350.2011.
Texto completo da fonteDedov, I. I., Ye A. Troshina, N. V. Mazurina e A. Belfiore. "Low expression of Met-hepatocytic growth factor receptor as an indicator of poor prognosis in thyroid tumors". Problems of Endocrinology 47, n.º 3 (15 de junho de 2001): 6–10. http://dx.doi.org/10.14341/probl11467.
Texto completo da fonteYou, Jingjing, Li Wen, Athena Roufas, Chris Hodge, Gerard Sutton e Michele C. Madigan. "Expression of HGF and c-Met Proteins in Human Keratoconus Corneas". Journal of Ophthalmology 2015 (2015): 1–8. http://dx.doi.org/10.1155/2015/852986.
Texto completo da fonteBlanquaert, Frederic, Renata C. Pereira e Ernesto Canalis. "Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts". American Journal of Physiology-Endocrinology and Metabolism 278, n.º 3 (1 de março de 2000): E509—E515. http://dx.doi.org/10.1152/ajpendo.2000.278.3.e509.
Texto completo da fonteBoschert, Verena, Nicola Klenk, Alexander Abt, Sudha Janaki Raman, Markus Fischer, Roman C. Brands, Axel Seher et al. "The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma". International Journal of Molecular Sciences 21, n.º 2 (11 de janeiro de 2020): 471. http://dx.doi.org/10.3390/ijms21020471.
Texto completo da fonteCao, Tong, Jing Pan, Xiulian Li, Yanli He, Yifei Jiang, Yajing Chang, Qi Zhang et al. "Isolation and Characterization of a Chinese Hamster Ovary Heparan Sulfate Cell Mutant Defective in Both Met Receptor Binding and Hepatocyte Growth Factor NK1/Met Signaling". Cellular Physiology and Biochemistry 48, n.º 4 (2018): 1480–91. http://dx.doi.org/10.1159/000492258.
Texto completo da fonteBeilmann, Mario, George F. Vande Woude, Hans-Peter Dienes e Peter Schirmacher. "Hepatocyte growth factor–stimulated invasiveness of monocytes". Blood 95, n.º 12 (15 de junho de 2000): 3964–69. http://dx.doi.org/10.1182/blood.v95.12.3964.
Texto completo da fonteBeilmann, Mario, George F. Vande Woude, Hans-Peter Dienes e Peter Schirmacher. "Hepatocyte growth factor–stimulated invasiveness of monocytes". Blood 95, n.º 12 (15 de junho de 2000): 3964–69. http://dx.doi.org/10.1182/blood.v95.12.3964.012k20_3964_3969.
Texto completo da fonteHay, Rick V., Brian Cao, R. Scot Skinner, Ling-Mei Wang, Yanli Su, James H. Resau, George F. Vande Woude e Milton D. Gross. "Radioimmunoscintigraphy of Tumors Autocrine for Human Met and Hepatocyte Growth Factor/Scatter Factor". Molecular Imaging 1, n.º 1 (1 de janeiro de 2002): 153535002002000. http://dx.doi.org/10.1162/15353500200200006.
Texto completo da fonteTonomura, Hitoshi, Masateru Nagae, Ryota Takatori, Hidenobu Ishibashi, Tomonori Itsuji e Kenji Takahashi. "The Potential Role of Hepatocyte Growth Factor in Degenerative Disorders of the Synovial Joint and Spine". International Journal of Molecular Sciences 21, n.º 22 (18 de novembro de 2020): 8717. http://dx.doi.org/10.3390/ijms21228717.
Texto completo da fonteXu, Chuanhui, Anke Van Den Berg, Wouter Plattel, Nele Ruther, Huang Xin, Miao Wang, Gustaaf Van Imhoff et al. "Expression of the c-Met Oncogene Correlates with Favorable Progression Free Survival In Classical Hodgkin Lymphoma". Blood 116, n.º 21 (19 de novembro de 2010): 3880. http://dx.doi.org/10.1182/blood.v116.21.3880.3880.
Texto completo da fonteSweis, Randy F., Petros Grivas, Alexander T. Pearson, Kathleen C. Day, Mark L. Day e Maha Hussain. "Expression of MET and HGF in bladder cancer tumorigenesis and invasion." Journal of Clinical Oncology 30, n.º 15_suppl (20 de maio de 2012): 4573. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.4573.
Texto completo da fonteBeilmann, Mario, Margarete Odenthal, Waltraud Jung, George F. Vande Woude, Hans-Peter Dienes e Peter Schirmacher. "Neoexpression of the c-met/Hepatocyte Growth Factor-Scatter Factor Receptor Gene in Activated Monocytes". Blood 90, n.º 11 (1 de dezembro de 1997): 4450–58. http://dx.doi.org/10.1182/blood.v90.11.4450.
Texto completo da fonteBeilmann, Mario, Margarete Odenthal, Waltraud Jung, George F. Vande Woude, Hans-Peter Dienes e Peter Schirmacher. "Neoexpression of the c-met/Hepatocyte Growth Factor-Scatter Factor Receptor Gene in Activated Monocytes". Blood 90, n.º 11 (1 de dezembro de 1997): 4450–58. http://dx.doi.org/10.1182/blood.v90.11.4450.4450_4450_4458.
Texto completo da fonteTjin, Esther P. M., Richard W. J. Groen, Irma Vogelzang, Patrick W. B. Derksen, Melanie D. Klok, Helen P. Meijer, Susanne van Eeden, Steven T. Pals e Marcel Spaargaren. "Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma". Blood 107, n.º 2 (15 de janeiro de 2006): 760–68. http://dx.doi.org/10.1182/blood-2005-05-1929.
Texto completo da fonteSierra, J. Rafael, e Ming-Sound Tsao. "c-MET as a potential therapeutic target and biomarker in cancer". Therapeutic Advances in Medical Oncology 3, n.º 1_suppl (novembro de 2011): S21—S35. http://dx.doi.org/10.1177/1758834011422557.
Texto completo da fonteBorset, Magne, Hakon Hov, Randi U. Holt, Torstein B. Ro, Unn-Merete Fagerli, Henrik Hjorth-Hansen, Vadim Baykov, James G. Christensen, Anders Waage e Anders Sundan. "A Selective Inhibitor of c-Met Blocks an Autocrine HGF Growth Loop in ANBL-6 Cells and Prevents Migration and Adhesion of Myeloma Cells." Blood 104, n.º 11 (16 de novembro de 2004): 2358. http://dx.doi.org/10.1182/blood.v104.11.2358.2358.
Texto completo da fonteCerqua, Marina, Orsola Botti, Maddalena Arigoni, Noemi Gioelli, Guido Serini, Raffaele Calogero, Carla Boccaccio, Paolo M. Comoglio e Dogus M. Altintas. "MET∆14 promotes a ligand-dependent, AKT-driven invasive growth". Life Science Alliance 5, n.º 10 (30 de maio de 2022): e202201409. http://dx.doi.org/10.26508/lsa.202201409.
Texto completo da fonteUzumcu, Mehmet, Zui Pan, Yi Chu, Peter E. Kuhn e Rob Zachow. "Immunolocalization of the hepatocyte growth factor (HGF) system in the rat ovary and the anti-apoptotic effect of HGF in rat ovarian granulosa cells in vitro". Reproduction 132, n.º 2 (agosto de 2006): 291–99. http://dx.doi.org/10.1530/rep.1.00989.
Texto completo da fonteMiranda, Oshin, Mariya Farooqui e Jill Siegfried. "Status of Agents Targeting the HGF/c-Met Axis in Lung Cancer". Cancers 10, n.º 9 (21 de agosto de 2018): 280. http://dx.doi.org/10.3390/cancers10090280.
Texto completo da fonteKempe, Sabrina. "MET-Inhibitoren sperren Ausweichroute über HGF/c-MET-Signalweg". Im Fokus Onkologie 25, n.º 2 (abril de 2022): 29–33. http://dx.doi.org/10.1007/s15015-022-3829-8.
Texto completo da fonteRicci, G., A. Catizone e M. Galdieri. "Expression and functional role of hepatocyte growth factor and its receptor (c-met) during fetal mouse testis development". Journal of Endocrinology 191, n.º 3 (dezembro de 2006): 559–70. http://dx.doi.org/10.1677/joe.1.06879.
Texto completo da fonteBuchynska, L. G., O. V. Brieieva e S. V. Nespriadko. "EXPRESSION OF HEPATOCYTE GROWTH FACTOR AND C-MET RECEPTOR IN STROMAL FIBROBLASTS AND TUMOR CELLS OF ENDOMETRIAL CARCINOMA". Experimental Oncology 45, n.º 1 (2023): 79–87. http://dx.doi.org/10.15407/exp-oncology.2023.01.079.
Texto completo da fonteXu, Chuanhui, Anke Van Den Berg, Arjan Diepstra, Miao Wang, Debora Jong, Hans JTWM Vos, Peter Moller, Sibrand Poppema e Lydia Visser. "The HGF/c-Met Signaling Pathway in Hodgkin Lymphoma." Blood 114, n.º 22 (20 de novembro de 2009): 1551. http://dx.doi.org/10.1182/blood.v114.22.1551.1551.
Texto completo da fonteElliott, Bruce E., Wesley L. Hung, Alexander H. Boag e Alan B. Tuck. "The role of hepatocyte growth factor (scatter factor) in epithelialmesenchymal transition and breast cancer". Canadian Journal of Physiology and Pharmacology 80, n.º 2 (1 de fevereiro de 2002): 91–102. http://dx.doi.org/10.1139/y02-010.
Texto completo da fonteTsubaki, Masanobu, Shiori Seki, Tomoya Takeda, Akiko Chihara, Yuuko Arai, Yuusuke Morii, Motohiro Imano, Takao Satou, Kazunori Shimomura e Shozo Nishida. "The HGF/Met/NF-κB Pathway Regulates RANKL Expression in Osteoblasts and Bone Marrow Stromal Cells". International Journal of Molecular Sciences 21, n.º 21 (24 de outubro de 2020): 7905. http://dx.doi.org/10.3390/ijms21217905.
Texto completo da fonteChattopadhyay, Naibedya, R. J. MacLeod, Jacob Tfelt-Hansen e Edward M. Brown. "1α,25(OH)2-vitamin D3inhibits HGF synthesis and secretion from MG-63 human osteosarcoma cells". American Journal of Physiology-Endocrinology and Metabolism 284, n.º 1 (1 de janeiro de 2003): E219—E227. http://dx.doi.org/10.1152/ajpendo.00247.2002.
Texto completo da fonteUMITSU, Masataka, e Junichi TAKAGI. "Structural basis of HGF-Met signaling". Japanese Journal of Thrombosis and Hemostasis 27, n.º 1 (2016): 77–84. http://dx.doi.org/10.2491/jjsth.27.77.
Texto completo da fonteZhou, Hong, Yuen Pon e Alice Wong. "HGF/MET Signaling in Ovarian Cancer". Current Molecular Medicine 8, n.º 6 (1 de setembro de 2008): 469–80. http://dx.doi.org/10.2174/156652408785747933.
Texto completo da fonteJalili, Ali, Neeta Shirvaikar, Sara Ilnitsky, A. Robert Turner, Mariusz Z. Ratajczak e Anna Janowska-Wieczorek. "G-CSF Induces Expression of Both Hepatocyte Growth Factor (HGF) and Its Receptor (c-Met) in Human Hematopoietic Stem/Progenitor Cells and Mature Myeloid Cells - Novel Evidence That during Mobilization the HGF-c-Met Axis Counterbalances G-CSF-Induced Attenuation of the SDF-1-CXCR4 Axis." Blood 110, n.º 11 (16 de novembro de 2007): 2203. http://dx.doi.org/10.1182/blood.v110.11.2203.2203.
Texto completo da fonteLiu, Y., E. M. Tolbert, A. M. Sun e L. D. Dworkin. "Primary structure of rat HGF receptor and induced expression in glomerular mesangial cells". American Journal of Physiology-Renal Physiology 271, n.º 3 (1 de setembro de 1996): F679—F688. http://dx.doi.org/10.1152/ajprenal.1996.271.3.f679.
Texto completo da fonteZachow, Rob, e Mehmet Uzumcu. "The hepatocyte growth factor system as a regulator of female and male gonadal function". Journal of Endocrinology 195, n.º 3 (13 de setembro de 2007): 359–71. http://dx.doi.org/10.1677/joe-07-0466.
Texto completo da fonte